Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery

NCT06769087 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 316

Last updated 2025-01-10

No results posted yet for this study

Summary

The enhanced recovery after surgery (ERAS) program is widely applied in colorectal cancer surgery. Among the early recovery programs after surgery, the timing of removal of the urinary catheter after surgery has been emphasized recently, but the specific timing is still under discussion. Maintaining the urinary catheter after surgery is to prevent urinary retention after surgery, but it is known that the risk of urinary tract infection increases the longer it is maintained. Previously, it was removed 3 days after colorectal cancer surgery, but several studies reported that even if it was removed earlier, the incidence of urinary retention did not increase, and rather the incidence of urinary tract infection decreased. In particular, by applying the early recovery program after surgery, factors related to patient recovery before, during, and after surgery are applied to help rapid recovery, and it has been reported that early removal of the urinary catheter has a positive effect on postoperative recovery and complications. Therefore, it is necessary to prove that the timing of removal of the urinary catheter after surgery in colorectal cancer patients can help early recovery through clinical results such as patient recovery and occurrence of complications.

Conditions

  • Colorectal Cancer
  • Postoperative Complication
  • Urinary Retention Postoperative
  • Enhanced Recovery After Surgery

Interventions

DEVICE

Immediate urinary catheter removal

A urinary catheter is removed immediately after surgery and before general anesthesia wears off in the operating room.

DEVICE

urinary catheter removal within postoperative 1day

The urethral catheter will be removed in the ward within 1 day after surgery (within 24 hours after surgery).

Sponsors & Collaborators

  • Eunpyeong St. Mary's Hospital, The Catholic University of Korea

    collaborator UNKNOWN
  • Catholic University of Korea, Yeouido St. Mary's Hospital

    collaborator UNKNOWN
  • The Catholic University of Korea Uijeongbu St.Marys Hostpial

    collaborator UNKNOWN
  • Catholic University of Korea, St. Vincent Hospital

    collaborator UNKNOWN
  • Incheon St.Mary's Hospital/The Catholic University

    collaborator UNKNOWN
  • Seoul St. Mary's Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06769087 on ClinicalTrials.gov